Date of Award
1-1-2013
Document Type
Masters Thesis
Degree Name
M.A.
Organizational Unit
College of Arts Humanities and Social Sciences
First Advisor
Peter Ho, Ph.D.
Second Advisor
Markus Schneider
Third Advisor
Yavuz Yasar
Keywords
Drug, Patent, Pharmaceutical
Abstract
This paper seeks to determine if extended patent terms can positively effect the production of drugs that treat rare diseases. It reviews the structure of the modern pharmaceutical company and considers the regulatory history that lead to this structure. The paper applies historically significant economic research in the field of patents and considers patent alternatives to establish the best method for incentivizing the development of these drugs. The paper finds that while there are numerous pitfalls and issues with the patent method, there are no viable alternatives. It also concludes that extending patent terms for drugs that treat rare diseases can act as a catalyst to orphan drug development.
Publication Statement
Copyright is held by the author. User is responsible for all copyright compliance.
Rights Holder
Joanna Louise Thompson
Provenance
Received from ProQuest
File Format
application/pdf
Language
en
File Size
100 p.
Recommended Citation
Thompson, Joanna Louise, "The Case for Extending Patent Terms for Drugs That Treat Rare Diseases" (2013). Electronic Theses and Dissertations. 648.
https://digitalcommons.du.edu/etd/648
Copyright date
2013
Discipline
Economics